Peak Planning Group’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $925K | Buy |
|
|||||
|
2025
Q4 | $882K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $789K | Sell |
|
|||||
|
2024
Q4 | $869K | Sell |
|
|||||
|
2024
Q3 | $1.12M | Sell |
|
|||||
|
2024
Q2 | $1.12M | Buy |
|
|||||
|
2024
Q1 | $1.1M | Buy |
|
|||||
|
2023
Q4 | $974K | Sell |
|
|||||
|
2023
Q3 | $970K | Sell |
|
|||||
|
2023
Q2 | $969K | Buy |
|
|||||
|
2023
Q1 | $869K | Buy |
|
|||||
|
2022
Q4 | $793K | Buy |
|
|||||
|
2022
Q3 | $686K | Buy |
|
|||||
|
2022
Q2 | $722K | Buy |
|
|||||
|
2021
Q4 | $731K | Sell |
|
|||||
|
2021
Q3 | $715K | Buy |
|
|||||
|
2021
Q1 | $548K | Buy |
|
|||||
|
2020
Q4 | $438K | Buy |
|
|||||
|
2020
Q3 | $387K | Buy |
|